Showing results (51-60 of 93) with videos related to
Sort By:
Pageof 10
Thrombosis Research|June 30, 2009
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)Alfonso Iorio, Walter Ageno, Benilde Cosmi, et al.Thrombosis Research|June 2, 2009
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study)Davide Imberti, Cristina Legnani, Edoardo Baldini, et al.Tumori|October 30, 2004
Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemiaDavide Imberti, Daniele Vallisa, Elisa Anselmi, et al.American Journal of Hematology|February 20, 2024
Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label studyMichelangelo Sartori, Matteo Iotti, Giuseppe Camporese, et al.Thrombosis Research|December 25, 2013
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum)Benilde Cosmi, Massimo Filippini, Fausto Campana, et al.Blood Transfusion = Trasfusione Del Sangue|January 22, 2011
Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhageDavide Imberti, Giovanni Barillari, Chiara Biasioli, et al.Internal and Emergency Medicine|November 1, 2019
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulantsPaolo Prandoni, Walter Ageno, Maurizio Ciammaichella, et al.Obesity Surgery|October 29, 2013
Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study)Davide Imberti, Edoardo Baldini, Matteo Giorgi Pierfranceschi, et al.Chronobiology International|February 9, 2016
"Timing" of arrival and in-hospital mortality in a cohort of patients under anticoagulant therapy presenting to the emergency departments with cerebral hemorrhage: A multicenter chronobiological study in ItalyFabio Fabbian, Roberto Manfredini, Alfredo De Giorgi, et al.Internal and Emergency Medicine|July 23, 2016
The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registryFrancesco Guercini, Valeria Mommi, Giuseppe Camporese, et al.Pageof 10